Overall, this study establishes a novel prognostic signature for prostate cancer and elucidates the potential role of ICD/ferroptosis-related pathways, particularly the TREX1-mediated DNA sensing mechanism, in the progression of prostate cancer. Here, TREX1 is linked to prostate cancer.